Cantrell W, Lee P, Mendelsohn AM, Parno J, Rozzo SJ, Liao W. Efficacy and Safety of Tildrakizumab 100 Mg for Plaque Psoriasis in Patients Randomized to Treatment Continuation vs Treatment Withdrawal with Retreatment upon Relapse in Resurface 1. J of Skin [Internet]. 2020Sep.2 [cited 2025Jan.10];4(5):s40. Available from: https://skin.dermsquared.com/skin/article/view/989